EIM
RGNX icon

Essex Investment Management’s Regenxbio RGNX Stock Holding History

Essex Investment Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-26,503
Closed -$601K – 418
2022
Q4 		$601K Buy
+26,503
New +$599K 0.09% 237
2020
Q4 		– Sell
-36,310
Closed -$999K – 508
2020
Q3 		$999K Buy
36,310
+21,197
+140% +$691K 0.14% 215
2020
Q2 		$557K Buy
+15,113
New +$563K 0.09% 242

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Essex Investment Management's RGNX Position: Q1 2023 in Review

Essex Investment Management sold out of Regenxbio (RGNX) in Q1 2023, closing a stake of 26,503 shares — an estimated $601K sold.

Essex Investment Management first reported a position in RGNX in Q2 2020 and held it in 3 quarters. The position peaked at $999K in Q3 2020. 174 funds tracked by Wall St. Rank hold RGNX as of Q1 2023.

  • Essex Investment Management reported no remaining Regenxbio position as of Q1 2023 after selling out during the quarter.
  • Essex Investment Management sold 26,503 Regenxbio shares in Q1 2023, an estimated $601K.
  • Essex Investment Management first reported a position in Regenxbio in Q2 2020 and held it in 3 quarters.
  • Essex Investment Management's Regenxbio position peaked at $999K in Q3 2020.
  • 174 funds tracked by Wall St. Rank held Regenxbio as of Q1 2023.

Based on Essex Investment Management's 13F filing for Q1 2023, filed 4 May 2023.